Ziqiang Zhu, M.D.

Dr. Zhu is a board certified internist working in Queens, NY.  He attended Zhejiang University School of Medicine and Peking Union Medical College (PUMC) in China and graduated with honor. Dr. Zhu finished Internal Medicine residency training at the New York Medical College/Brookdale University Hospital and Medical Center and has been practicing since then. Besides clinical practice, Dr. Zhu is also interested in medical research. He completed postdoctoral training at University of Louisville in Kentucky and later at National Institutes of Health (NIH) in Maryland. His research focused on the novel therapies for type II diabetes and immunotherapy for metastatic cancer. Dr. Zhu published over 30 original papers and has been invited multiple times to speak in national and international conferences. In 2017, Dr. Zhu joined Mount Sinai Elmhurst Hospital Center as a faculty member in the Department of Medicine. He works in the observation unit caring the most diverse patient population of Queens, NY. Dr. Zhu also affiliated with NewYork-Presbyterian Queens. Zhu is fluent in both Mandarin and English. He currently accepts new patients.

PUBLICATIONS:

  1. Xu H, Zhu Z, Huang Y, Ildstad ST. FL/GCSF/AMD3100 Mobilized Hematopoietic Stem Cells Induce Mixed Chimerism With Nonmyeloablative Conditioning and Transplantation Tolerance.   2019 Feb 4
  2. Zhu Z, Liu W, Mamlouk O, O’Donnell JE, Sen D, Avezbakiyev B. Primary Pulmonary Diffuse Large-B-Cell non-Hodgkin’s Lymphoma, a Case Report and Review of the Literature. Am J Case Rep. 2017 Mar 21
  3. Zhang F, Zhu Z, Upadhya G, Gotlieb V, Khan A, Pupta RP. Papillary Fibroelastoma of the Aortic Valve: An Unusual Case Presented with Chronic Angina and Acute Stroke. J Med Case Rep. 2017 Jan 18;11(1):17
  4. Habeeb NW, Kulasingam V, Diamandis EP, Yousef GM, Tsongalis GJ, Vermeulen L, Zhu Z, Kamel-Reid S, The use of targeted therapies for precision medicine in oncology, Clin Chem. 2016 Dec;62(12):1556-1564
  5. Chhibar P, Zhu Z, Cheedella NK, Chaudhry R, Wang JC. Hepatitis B Reactivation After Ifosfamide Therapy for   Retroperitoneal Sarcoma. Am J Case Rep. 2016 Jun 1;17:371-4
  6. Zhu Z, Chen H, Gill R, Wang J, Spitalewitz S, Gotlieb V., Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report. J Med Case Rep. 2016 Feb 24;10(1):38
  7. Zhu Z., Liu W., Gotlieb V., The Rapidly Evolving Therapies for Advanced Melanoma —Towards Immunotherapy, Molecular Targeted Therapy, and Beyond. Crit Rev Oncol Hematol. 2015 Dec 10.
  8. Zhu Z., Cuss S., Singh V., Gurusamy D., Shoe J., Leighty R.; Bronte V., Hurwitz AA. “CD4 T Cell Help Selectively Enhances High-Avidity Tumor Antigen Specific CD8 T cells. J Immunol. 2015 Aug 28
  9. Zhu Z., Shahzad A., Rozin A. Myopericarditis and atrial fibrillation complicating meningococcal meningitis in a human immunodeficiency virus-infected man who has sex with men: a case report. JMM Case Reports, 2015
  10. Zhu Z., Aghaie,S., Bandarchuk A., Gandhi A., Rhabdomyolysis and acute kidney injury in salmonella gastroenteritis: A case report and review of the literature. Int J Case Rep Images., 2015; 6(4):233-238
  11. Hurwitz AA, Cuss SM, Stagliano KE, Zhu Z. T cell avidity and tumor immunity: problems and solutions. Cancer Microenviron. 2014 Aug;7(1-2):1-9
  12. Zhu Z., Dhir T., Soe M., Green L., Jiang N.. Hepatitis C prevalence in HIV-infected individuals: A comparison of inpatient and outpatient care. Int J STD AIDS. 2014 Oct;25(11):806-11
  13. McGray AR., Hallett R., Bernard D,; Swift S., Zhu Z., Teoderascu F., VanSeggelen H., Hassell J., Huwtitz AA., Wan YH., Bramson J.. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Ther. 2014 Jan;22(1):206-18
  14. Zhu Z., Singh V., Watkins SK., Feigenbaum L., Shoe J., Bronte V., Hurwitz AA. “High Avidity T Cells are Preferentially Tolerized in the Tumor Microenvironment.Cancer Research. 2013;73(2):595-604
  15. Xu H., Yan J., Zhu Z., Hussain LR., Huang Y., Ding C., Bozulic LD., Wen Y., Ildstand ST. “A Critical Role for the TLR4/TRIF Pathway in Allogeneic Hematopoietic Cell Rejection by Innate Immune Cell.” Cell Transplantation. 2012 Nov 8.
  16. Xu H., Zhu Z., Huang Y, Bozulic LD, Hussain LR., Yan, J., Ildstad ST. Innate and Adaptive Immune Responses are Tolerized in Chimeras Prepared with Nonmyeloablative Conditioning. Transplantation. 93(5): 469-76.2012.
  17. Xu, H., Huang, Y.M., Hussain, L.R., Zhu, Z., Bozulic, L.D., Ding, C., Yan, J., Ildstad ST. Sensitization to Minor Antigens is a Significant Barrier in Bone Marrow Transplantation and is Prevented by CD154:CD40 Blockade. American Journal of Transplantation,10(7), 1569-1579, 2010
  18. Zhu, Z., Liu, W., Xu, C.L., Han, S., Zu, S., and Zhu, G. Reference Data for Quantitative Ultrasound Values of Calcaneus in 2927 Healthy Chinese Men. Journal of Bone and Mineral Metabolism 26: 165-171, 2008.
  19. Zhu, Z., Liu, W., Xu, C.L., Han, S., Zu, S., and Zhu, G. Ultrasound Bone Densitometry of the Calcaneus in Healthy Chinese Children and Adolescents. Osteoporosis International 18: 533-541, 2007.
  20. Liu, W., Zhu, Z (Co-first author)., Wang, W., Zu, S.Y., and Zhu, G. Crucial Roles of GATA-2 and SP-1 in Adrenomedullin Affected Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells Exposed to Lipopolysaccharide. Thrombosis and Haemostasis 97: 839-846, 2007.
  21. Liu, W., Xu, C.L., Zhu, Z., Han, S., Zu, S., and Zhu, G. Assessment of Low Quantitative Ultrasound Values of Calcaneus in Chinese Mainland Women. Journal of Clinical Densitometry 9: 351-357, 2006.
  22. Liu, W., Xu, C.L., Zhu, Z., Han, S., Zu, S., and Zhu, G. Characteristics of Calcaneus Quantitative Ultrasound Normative Data in Chinese Mainland Men and Women. Osteoporosis International 17: 1216-1224, 2006.